Common Breast Cancer Gene Test May Be Flawed, Study Says - Health News - Health.com
Friday, April 27th, 2012Latest news:

FRIDAY, Nov. 4 (HealthDay Newsworthiness) — A wide put-upon front cancer tryout may not be exact in identifying a factor that is vital in determinative which life-saving discussion a char should get.
The Oncotype DX, marketed by Genomic Wellness, results in a numeral of false-negatives for the HER2 factor, according to a bailiwick promulgated Oct. 18 in the Journal of Clinical Oncology.





